REGN
Regeneron Pharmaceuticals Inc
$769.33
0.00%
0.00
Notify me if price changes either direction
Buy REGN stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
81.7B
Enterprise value
72.5B
Trailing PE
18.485258
Forward PE
17.146467
PEG Ratio
1.3563147881657
Enterprise to EBITDA
16.676
Enterprise to revenue
5.089
Price to book MRQ
2.5609007
Price to sales TTM
5.736889
Financials
Fiscal Year Ends
2024-12-31
Most Recent Quarter (MRQ)
2025-09-30
Revenue (TTM)
14.2B
EBITDA
5.0B
Diluted EPS TTM
41.72
Total Cash (MRQ)
8.4B
Current ratio (MRQ)
4.063
Operating Cash Flow (TTM)
5.1B
REGN trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
January 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
